ANN HANHAM
CIK 1286338 · last filed 2025-06-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$294.5K
Companies
3
Total Filings
44
Lifetime Open-Market Net
-$5.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCYX | Director | 69,622 | $4.23 | $294.5K | $35.4K | 19 | 2025-06-30 |
| HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Director | 7,304 | $0.48 | $3.5K | $0 | 8 | 2022-09-15 |
| ENDOCYTE INC (ECYT) Delisted | Director | 62,096 | — | — | -$5.37M | 17 | 2017-05-05 |
Recent Filings · Page 5 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-05-31 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-03-09 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-02-11 | ENDOCYTE INC (ECYT) Delisted | Mixed | +832,735 | $0 | EDGAR |
| 2011-02-08 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | +500,000 | $3.00M | EDGAR |
Showing 41–44 of 44
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.